Novartis announces data showing Jakavi more effective than best available therapy in acute GvHD Read more
Novartis Kymriah receives FDA Regenerative Medicine Advanced Therapy designation in follicular lymphoma Read more
Targovax and Valo Therapeutics Enter Collaboration to Develop RAS Neoantigen Coating of ONCOS Viruses Using PeptiCRAd Technology Read more
Mogrify and Sangamo Announce Collaboration and Exclusive License Agreement for Mogrify’s iPSC- and ESC-Derived Regulatory T Cells Read more